Literature DB >> 17897249

Osteoporosis and chronic kidney disease.

Anca Gal-Moscovici1, Stuart M Sprague.   

Abstract

Osteoporosis (OP), the most frequent bone disease affecting the general population, is associated with high fracture risk. Patients with impaired kidney function have bone and mineral disturbances leading to extraskeletal calcifications and complex changes in bone turnover that predispose them to increased fracture risk accompanied by increased morbidity and mortality. The combination of these two bone disorders seems to have an additive effect with regard to fracture risk and its outcome, so that appropriate diagnosis and treatment of this disorder should be of primary concern when approaching patients with kidney disease. Nevertheless, the clinical and laboratory diagnostic tools used to identify OP in the general population do not suit the requirement for detecting the complex bone and metabolic changes that occur with chronic kidney disease, leading to the lack of or the initiation of inappropriate therapy. This review will focus on the bone pathophysiologic processes involved in OP and renal osteodystrophy and address some of the problems associated with our current diagnostic tools and aspects of the therapeutic approaches.

Entities:  

Mesh:

Year:  2007        PMID: 17897249     DOI: 10.1111/j.1525-139X.2007.00319.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  25 in total

1.  Use of oral bisphosphonates by older adults with fractures and impaired renal function.

Authors:  Cheryl A Sadowski; Tara Spencer; Nese Yuksel
Journal:  Can J Hosp Pharm       Date:  2011-01

2.  An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.

Authors:  L Caplan; A E Hines; E Williams; A V Prochazka; K G Saag; F Cunningham; E Hutt
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

3.  Bone microarchitecture in hemodialysis patients assessed by HR-pQCT.

Authors:  Daniel Cejka; Janina M Patsch; Michael Weber; Danielle Diarra; Markus Riegersperger; Zeljko Kikic; Christian Krestan; Claudia Schueller-Weidekamm; Franz Kainberger; Martin Haas
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

Review 4.  Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options.

Authors:  C Early; L Stuckey; S Tischer
Journal:  Osteoporos Int       Date:  2015-10-16       Impact factor: 4.507

5.  Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis.

Authors:  Y Nagata; M Inaba; Y Imanishi; H Okazaki; S Yamada; K Mori; S Shoji; H Koyama; S Okuno
Journal:  Osteoporos Int       Date:  2014-11-18       Impact factor: 4.507

6.  Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients.

Authors:  A L Negri; E E Del Valle; M B Zanchetta; M Nobaru; F Silveira; M Puddu; R Barone; C E Bogado; J R Zanchetta
Journal:  Osteoporos Int       Date:  2012-01-11       Impact factor: 4.507

Review 7.  Chronic kidney disease and bone fracture: a growing concern.

Authors:  Thomas L Nickolas; Mary B Leonard; Elizabeth Shane
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

Review 8.  The role of bone biopsy in patients with chronic renal failure.

Authors:  Paul D Miller
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 9.  Chronic kidney disease and osteoporosis: evaluation and management.

Authors:  Paul D Miller
Journal:  Bonekey Rep       Date:  2014-06-25

10.  Factors associated with low bone mass in the hemodialysis patients--a cross-sectional correlation study.

Authors:  Guey-Shiun Huang; Tzong-Shinn Chu; Meei-Fang Lou; Shiow-Li Hwang; Rong-Sen Yang
Journal:  BMC Musculoskelet Disord       Date:  2009-06-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.